Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angong Niuhuang Wan for Stroke
NCT04236427Phase 3Unknown
- Sponsor
- The Chinese University of Hong Kong
- Start
- Oct 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Angong Niuhuang Pill in stroke, Transient Ischemic Attack (TIA), sponsored by The Chinese University of Hong Kong. Status: unknown.
02
Drugs
Angong Niuhuang Pill
03
Conditions
strokeTransient Ischemic Attack (TIA)
Beyond the preview
Go deeper on NCT04236427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04236427.